Context: You are an assistant in a pharmaceutical company. Your department head has asked you to design a new drug.
User: The drug should have a acute oral toxicity rat LD50 of 1000.0 mg/kg, 2 Ghose filter violations, 0 lead likeness filter violations, 0 violations of the Lipinski rules, 467.650 molecular mass g/mol, 29 carbon atoms, and 4 oxygen atoms.
Assistant: Of course The compound with the SMILES representation of COC12CCC3(CC1C(C)(O)C(C)(C)C)C1Cc4ccc(O)c5c4C3(CCN1CC1CC1)C2O5 exhibits the desired properties.

Context: You are {#an assistant|researcher|scientist!} in a pharmaceutical company. Your {#boss|superior|department head!} has asked you to {#design|create|synthesize!} a new drug.
User: The {#drug|compound|chemical!} should have a {CATMoS_LD50_mgkg__names__noun} of {CATMoS_LD50_mgkg#} {CATMoS_LD50_mgkg__units}, {num_ghose_violations#} {num_ghose_violations__names__noun}, {num_lead_likeness_violations#} {num_lead_likeness_violations__names__noun}, {num_lipinski_violations#} {num_lipinski_violations__names__noun}, {molecular_mass#} {molecular_mass__names__noun} {molecular_mass__units}, {num_carbon_atoms#} {num_carbon_atoms__names__noun}, and {num_oxygen_atoms#} {num_oxygen_atoms__names__noun}.
Assistant: {#Happy to help!|Sure!|Of course!} The {#molecule|chemical|compound!} with the {SMILES__description} {#representation of |!}{SMILES#} {#shows|exhibits|displays!} the desired properties.

5-(cyclopropylmethyl)-16-(2-hydroxy-3,3-dimethylbutan-2-yl)-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-11-ol